ImmunologybioRxivPreprint
CD200 depletion in glioma enhances antitumor immunity and induces tumor rejection
Itay Raphael, Anzar Mujeeb, Elisabet Ampudia-Mesias…·Michael R. Olin
This study shows that CD200 depletion in gliomas enhances antitumor immunity and leads to tumor rejection by modulating immune cell activity and cytokine expression.
3 citations